相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045
Hong Sun et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2022)
Effects of dapagliflozin in the progression of atherosclerosis in patients with type 2 diabetes: a meta-analysis of randomized controlled trials
Qian-Long Wu et al.
DIABETOLOGY & METABOLIC SYNDROME (2022)
Anti-oxidant and anti-inflammatory effects of auraptene on phytohemagglutinin (PHA)-induced inflammation in human lymphocytes
Vahid Reza Askari et al.
PHARMACOLOGICAL REPORTS (2021)
Lipoprotein(a) and Cardiovascular Disease
Pia R. Kamstrup
CLINICAL CHEMISTRY (2021)
Curcumin Nanomicelle Improves Lipid Profile, Stress Oxidative Factors and Inflammatory Markers in Patients Undergoing Coronary Elective An- gioplasty; A Randomized Clinical Trial
Bijan Helli et al.
ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS (2021)
Lipoprotein(a) and Cardiovascular Diseases
Hannah Miksenas et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Colchicine effectively attenuates inflammatory biomarker high-sensitivity C-reactive protein (hs-CRP) in patients with non-ST-segment elevation myocardial infarction: a randomised, double-blind, placebo-controlled clinical trial
Arash Gholoobi et al.
INFLAMMOPHARMACOLOGY (2021)
Preparation and characterization of stable nanoliposomal formulations of curcumin with high loading efficacy: In vitro and in vivo anti-tumor study
Maryam Karimi et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)
Aerobic exercise and nano-curcumin supplementation improve inflammation in elderly females with metabolic syndrome
Ali Osali
DIABETOLOGY & METABOLIC SYNDROME (2020)
Trends in the incidence of diabetes mellitus: results from the Global Burden of Disease Study 2017 and implications for diabetes mellitus prevention
Jinli Liu et al.
BMC PUBLIC HEALTH (2020)
Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with nonalcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial
Seyed Ali Jazayeri-Tehrani et al.
NUTRITION & METABOLISM (2019)
Crocin protects cardiomyocytes against LPS-Induced inflammation
Vafa Baradaran Rahim et al.
PHARMACOLOGICAL REPORTS (2019)
Ellagic acid dose and time-dependently abrogates D-galactose-induced animal model of aging: Investigating the role of PPAR-γ
Vafa Baradaran Rahimi et al.
LIFE SCIENCES (2019)
Curcumin: Biological, Pharmaceutical, Nutraceutical, and Analytical Aspects
Raghavendhar R. Kotha et al.
MOLECULES (2019)
Risk of early mortality and cardiovascular disease in type 1 diabetes: a comparison with type 2 diabetes, a nationwide study
You-Bin Lee et al.
CARDIOVASCULAR DIABETOLOGY (2019)
Lipoprotein(a): An independent, genetic, and causal factor for cardiovascular disease and acute myocardial infarction
Enas A. Enas et al.
INDIAN HEART JOURNAL (2019)
A Novel Combination of ω-3 Fatty Acids and Nano-Curcumin Modulates Interleukin-6 Gene Expression and High Sensitivity C-reactive Protein Serum Levels in Patients with Migraine: A Randomized Clinical Trial Study
Mina Abdolahi et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2018)
Economic Burden of Cardiovascular Disease in Type 2 Diabetes: A Systematic Review
Thomas R. Einarson et al.
VALUE IN HEALTH (2018)
Risk factors for acute coronary syndrome in patients below the age of 40 years
Aram J. Mirza et al.
EGYPTIAN HEART JOURNAL (2018)
Type-2 diabetes mellitus and cardiovascular disease
Robert J. Henning
FUTURE CARDIOLOGY (2018)
Curcumin, an active component of turmeric (Curcuma longa), and its effects on health
Betul Kocaadam et al.
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2017)
Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases
Ajaikumar B. Kunnumakkara et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Curcuminoids modify lipid profile in type 2 diabetes mellitus: A randomized controlled trial
Yunes Panahi et al.
COMPLEMENTARY THERAPIES IN MEDICINE (2017)
Curcumin, Inflammation, and Chronic Diseases: How Are They Linked?
Yan He et al.
MOLECULES (2015)
Solubility Enhancement and Delivery Systems of Curcumin a Herbal Medicine: A Review
Umme Hani et al.
CURRENT DRUG DELIVERY (2014)
High-sensitivity C-reactive protein and atherosclerotic disease: From improved risk prediction to risk-guided therapy
Wolfgang Koenig
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Long-term curcumin administration protects against atherosclerosis via hepatic regulation of lipoprotein cholesterol metabolism
Su-Kyung Shin et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2011)
Dyslipidemia in type 2 diabetes mellitus
Arshag D. Mooradian
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM (2009)
Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis in Myocardial Infarction 38
Stephen D. Wiviott et al.
CIRCULATION (2008)
Bioavailability of curcumin: Problems and promises
Preetha Anand et al.
MOLECULAR PHARMACEUTICS (2007)
High-sensitivity C-reactive protein as a risk assessment tool for cardiovascular disease.
ETH Yeh
CLINICAL CARDIOLOGY (2005)
分享论文
